# The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery

> **NCT02139241** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 114 (actual)

## Conditions studied

- Coronary Artery Bypass Graft Triple Vessel
- Hypotension

## Interventions

- **DRUG:** Ramosetron
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02139241
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2015-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139241, "The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02139241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*